Channel 1
ESMO Colloquium
Date
22.09.2020
Time
13:00 - 14:30
Room
Channel 1
Chairs
- Alexander Drilon (New York, NY, United States of America)
- Giuseppe Curigliano (Milan, Italy)
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
ESMO Colloquium
Introduction
Lecture Time
13:00 - 13:05
Speakers
- Giuseppe Curigliano (Milan, Italy)
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
ESMO Colloquium
Introduction to RET mutations and fusions and their incidence for potential use as target in cancer treatment
Lecture Time
13:05 - 13:20
Speakers
- Alexander Drilon (New York, NY, United States of America)
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
ESMO Colloquium
RET fusion TKI: Present results and recent developments in Lung cancer
Lecture Time
13:20 - 13:35
Speakers
- David Planchard (Villejuif, France)
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
ESMO Colloquium
RET alterations in Thyroid carcinomas: Results and recent update
Lecture Time
13:35 - 13:50
Speakers
- Lori J. Wirth (Boston, MA, United States of America)
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
ESMO Colloquium
RET determination: Present recommendation of the ESMO Precision Medicine working group
Lecture Time
13:50 - 14:05
Speakers
- Giuseppe Curigliano (Milan, Italy)
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
ESMO Colloquium
Conclusion: Is RET targeting ready for an agnostic use?
Lecture Time
14:05 - 14:10
Speakers
- Alexander Drilon (New York, NY, United States of America)
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
ESMO Colloquium
Live Q&A
Lecture Time
14:10 - 14:30
Speakers
- Giuseppe Curigliano (Milan, Italy)
- Alexander Drilon (New York, NY, United States of America)
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30